Bentham Science Logo

Track Your Manuscript:


Current Cancer Drug Targets

Volume 22, 11 Issues, 2022
ISSN: 1873-5576 (Online)
ISSN: 1568-0096 (Print)
This journal supports open access

Contents

Current Cancer Drug Targets , Volume 11 - Number 3



Marizomib, a Proteasome Inhibitor for All Seasons: Preclinical Profile and a Framework for Clinical Trials

, 11(3): 254 - 284

G. K. Lloyd, M. A. Palladino, A. Younes, E. Valashi, M. A. Spear, C. M. Sloss, A. M. Roccaro, P. G. Richardson, F. Pajonk, H. Ovaa, Y. Oki, S. T.C. Neuteboom, C. P. Miller, D. J. McConkey, W. McBride, B. C. Potts, K. S. Lam, P. R. Jensen, M. Groll, I. M. Ghobrial, W. Fenical, J. C. Cusack, D. Chauhan, J. Chandra, B. Bonavida, C. Berkers, S. Baritaki, K. C. Anderson and M. X. Albitar


DOI: 10.2174/156800911794519716












Editor-in-Chief

Ruiwen Zhang
Center for Drug Discovery
University of Houston
Houston, TX
(USA)
Biography
View Full Editorial Board

COPE Compliant

Cope Logo

Advertisement

Mechanisms-of-Metabolic-Disorders-(MMD)

Related Journals

Related eBooks

eBooks Catalog